# EnobraQ

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enobraq

- Industry: Biotechnology
- Headquarters: Toulouse, France
- Website: www.enobraq.com
- Total disclosed funding: $5.4M
- Latest round: Series A (Nov 29, 2019)
- Investors on record: 5

## About

Based in Toulouse, France, and founded in 2015 by Michael Kre, EnobraQ operates as a biotechnology company that develops carbon dioxide-based fermentation processes. The company's CEO is Christophe Dardel. In April 2016, EnobraQ raised EUR 2.9 million in seed funding, co-led by Auriga Partners and Sofinnova Partners, with participation from CEA Investissement and IRDInov. The company raised another round of Seed funding of EUR 2 million in April 2018. 

EnobraQ develops fermentation processes to transform carbon dioxide into commodity chemicals and provides bio-based alternatives to fossil fuel-derived chemicals. The company provides solutions to the nutrition, agri-food, cosmetics, pharmacology, and bioplastics industries.

EnobraQ will use the seed funding to expand its fields of action and lead to the implementation of sustainable processes.

## Funding rounds

- Series A, Nov 29, 2019, $0.6M — Auriga Partners, Sofinnova Partners, CEA Investissement, IRDInov
- Series A, Sep 3, 2018, $2.4M — Auriga Partners, Sofinnova Partners, CEA Investissement, IRDInov, CNRS Innovation
- Series A, May 30, 2016, $2.4M — Auriga Partners, Sofinnova Partners, CEA Investissement, IRDInov

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- CEA Investissement (https://capitalatlas.ai/funds/cea-investissement) — Series A
- IRDInov — Series A
- CNRS Innovation — Series A